Need to strengthen pharma research: Union Minister Mansukh Mandaviya
New Delhi: Union Chemicals and Fertilizers Minister Mansukh Mandaviya on Monday said there is a need to strengthen research in the pharma sector and ensure close collaboration between research institutions and the industry.
He also highlighted the progress made by the pharma sector in the country and said it has emerged as the ''Pharmacy of World''.
"...We are ahead in formulations, but are lacking behind in research. How do we move ahead in research? For this a road map should emerge from the lecture series organised by NIPER...," Mandaviya said.
National Institute of Pharmaceutical Education and Research (NIPER) should also come up with a roadmap on how they can collaborate with the industry. So that they can share their knowledge with the world, he said while virtually inaugurating the celebrations of the iconic week, under Azadi ka Amrit Mahotsav, by NIPER Mohali.
The Ministry of Chemicals and Fertilizers is organising a week-long gamut of activities to celebrate Azadi ka Amrit Mahotsav during October 4-10.
Azadi Ka Amrit Mahotsav is an initiative of the government to celebrate and commemorate 75 years of progressive India and the glorious history of its people, culture and achievements.
"I expect that a document is prepared on the roadmap to be taken by NIPERs for their future growth, Mandaviya said.
On the occasion of celebrating 75 years of India's freedom, we must decide where we should take the pharma sector when the country celebrates 100 years of freedom, he added.
The Department of Pharmaceuticals is celebrating the iconic week with the theme "Story Of Pharma @75: Future Opportunities".
Under the initiative, Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) will organise health check-up camps and free distribution of first-aid kits at 750 Pradhan Mantri Bhartiya Janaushadhi Kendras across the country on October 10, the ministry said.
It will also conduct Jan Aushadhi Paricharcha for spreading awareness on generic drugs, it added.
Read also: Eli Lilly, Cipla ink pact for Humalog,Trulicity to treat diabetes
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.